A detailed history of Tocqueville Asset Management L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 195,895 shares of ABT stock, worth $22.4 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
195,895
Previous 247,460 20.84%
Holding current value
$22.4 Million
Previous $25.7 Million 13.15%
% of portfolio
0.36%
Previous 0.43%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $5.16 Million - $6.09 Million
-51,565 Reduced 20.84%
195,895 $22.3 Million
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $4.84 Million - $5.4 Million
48,032 Added 24.08%
247,460 $25.7 Million
Q1 2024

May 09, 2024

SELL
$109.52 - $120.96 $13.7 Million - $15.1 Million
-124,717 Reduced 38.48%
199,428 $22.7 Million
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $2.94 Million - $3.6 Million
-32,630 Reduced 9.15%
324,145 $35.7 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $1.86 Million - $2.23 Million
-19,440 Reduced 5.17%
356,775 $34.6 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $1.46 Million - $1.62 Million
-14,454 Reduced 3.7%
376,215 $41 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $232,076 - $273,167
-2,396 Reduced 0.61%
390,669 $39.6 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $850,787 - $998,104
8,950 Added 2.33%
393,065 $43.2 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $9,192 - $10,642
95 Added 0.02%
384,115 $37.2 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $20,414 - $24,674
-200 Reduced 0.05%
384,020 $41.7 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $258,255 - $314,925
-2,265 Reduced 0.59%
384,220 $45.5 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $248,505 - $304,280
2,151 Added 0.56%
386,485 $54.4 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $10.9 Million - $12 Million
93,265 Added 32.04%
384,334 $45.4 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $186,613 - $219,670
1,764 Added 0.61%
291,069 $33.7 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $115,588 - $136,180
-1,062 Reduced 0.37%
289,305 $34.7 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $20,475 - $22,311
-195 Reduced 0.07%
290,367 $31.8 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $2.11 Million - $2.57 Million
-23,068 Reduced 7.36%
290,562 $31.6 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $2.61 Million - $3.34 Million
-34,121 Reduced 9.81%
313,630 $28.7 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $1.29 Million - $1.88 Million
-20,520 Reduced 5.57%
347,751 $27.4 Million
Q4 2019

Jan 14, 2020

SELL
$78.51 - $87.4 $764,844 - $851,450
-9,742 Reduced 2.58%
368,271 $32 Million
Q3 2019

Oct 31, 2019

SELL
$81.84 - $88.74 $1.39 Million - $1.51 Million
-16,999 Reduced 4.3%
378,013 $31.6 Million
Q2 2019

Jul 31, 2019

SELL
$72.88 - $85.0 $329,854 - $384,710
-4,526 Reduced 1.13%
395,012 $33.2 Million
Q1 2019

Apr 30, 2019

SELL
$66.22 - $80.06 $2.13 Million - $2.58 Million
-32,173 Reduced 7.45%
399,538 $31.9 Million
Q4 2018

Feb 08, 2019

SELL
$65.56 - $74.27 $1.03 Million - $1.17 Million
-15,785 Reduced 3.53%
431,711 $31.2 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $1.89 Million - $2.28 Million
-31,047 Reduced 6.49%
447,496 $32.8 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $8.24 Million - $9.1 Million
-143,214 Reduced 23.03%
478,543 $29.2 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $9.04 Million - $10.2 Million
-160,587 Reduced 20.53%
621,757 $37.3 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $8.41 Million - $9 Million
-156,607 Reduced 16.68%
782,344 $44.6 Million
Q3 2017

Oct 30, 2017

BUY
$48.06 - $53.64 $45.1 Million - $50.4 Million
938,951
938,951 $50.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.